Takahashi H, Yoshimura M
2nd Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
J Cardiovasc Pharmacol. 1987;10 Suppl 10:S129-33.
Whether or not the central nervous system is involved in the genesis of hypertension in an individual patient, it becomes a major determinant of the responses to antihypertensive therapy once a treatment strategy is adopted. The major mechanisms through which the central nervous system influences blood pressure are sympathetic and parasympathetic nervous system activity and vasopressin release, either together or separately, but additional mechanisms may also contribute. When vasodilators are used, for example, the reactive increase in plasma catecholamines makes a substantial contribution to limiting the blood pressure fall. The sympathetic activation may lead to the reactive increase in plasma renin activity and sodium retention, which also plays an important role in limiting the antihypertensive action. Among newer agents, the effectiveness of calcium channel blockers could reflect a special action on the central nervous system that may contribute to reducing the reactive vasopressor responses. Treatment strategies that address the problem of the central nervous responses are more likely to be effective than approaches that avoid or ignore it.
在个体患者中,中枢神经系统是否参与高血压的发生,一旦采取治疗策略,它就成为抗高血压治疗反应的主要决定因素。中枢神经系统影响血压的主要机制是交感神经系统和副交感神经系统活动以及血管加压素释放,它们可共同或分别起作用,但也可能有其他机制参与。例如,使用血管扩张剂时,血浆儿茶酚胺的反应性增加对限制血压下降有很大作用。交感神经激活可能导致血浆肾素活性反应性增加和钠潴留,这在限制抗高血压作用方面也起重要作用。在新型药物中,钙通道阻滞剂的有效性可能反映了对中枢神经系统的特殊作用,这可能有助于减少反应性升压反应。解决中枢神经反应问题的治疗策略比回避或忽视该问题的方法更有可能有效。